Connect with MMS

MMS is the leading data-focused CRO dedicated to supporting your needs. To request more information or to speak with a representative from MMS, please use this form and one of our colleagues will contact you shortly.

MMS locations map
North America
MMS Holdings Inc.
6880 Commerce Blvd.
Canton, MI 48187, USA
info@mmsholdings.com
Asia
MMSH Clinical Research Pvt. Ltd.
2/1, Dr. Rajkumar Road,
Rajajinagar
Bangalore 560010, India
Asia@mmsholdings.com
Europe
Scottish Provident Building
3rd Floor Office,
Scottish Provident Building,
7 Donegall Square West,
Belfast, BT1 6JH
United Kingdom
Europe@mmsholdings.com
South Africa
Postnet Preller Suite 3
Private Bag X01
Heuwelsig 9332, Bloemfontein
South Africa
SA@mmsholdings.com
Asia
Sonthalia (Dwaraka)
Mindspace, Suite 401,
Madhapur Hyderabad 500081
India
Asia@mmsholdings.com

Suggested For You

news

February 5th, 2026

MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions 

perspectives

February 3rd, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

January 29th, 2026

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

ebook

January 27th, 2026

A Practical Guide to Expedited Regulatory Pathways

perspectives

January 27th, 2026

What Regulators Want to See in Surrogate Endpoints Today 

perspectives

January 20th, 2026

Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration 

perspectives

January 13th, 2026

Making Clinical Trial Technology Work in Practice

fact sheet

December 17th, 2025

Advance Psychedelic Drug Development With Proven Regulatory and Data Expertise

fact sheet

December 17th, 2025

Agile Medical Writing Staff Augmentation When You Need Expertise Not Headcount

fact sheet

December 17th, 2025

Biometrics Solutions Fact Sheet: End-to-End Data Expertise for Complex Clinical Trials

whitepaper

December 17th, 2025

Estimands: Opportunity or Risk for Drug Developers?

perspectives

December 16th, 2025

Inside Pharma and Biotech’s Shifting Landscape and the Direction Leaders Are Giving for 2026